Skip to content

Rishika Anil, MD

NPI 1548948904ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· Milwaukee, WI

Internal Medicine, Endocrinology, Diabetes & Metabolism (MD) in Milwaukee, Wisconsin, licensed in WI, with an NPI issued in July 2023. Part D covered 83 prescriptions written in 2024, 75% of them generic. Actelion Pharmaceuticals US, Inc. was the largest of 5 companies reporting payments in 2025, $204.00 in all, mostly food and beverage.

Overview

NPI1548948904
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedJul 6, 2023
Last updated in NPPESJul 14, 2026
Certified by providerJul 14, 2026

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine, Endocrinology, Diabetes & Metabolism Primary207RE0101XNO.87148-20WI

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 4, 2026No match—
New York OMIG · Nov 4, 2026No match—
Ohio Medicaid · Nov 4, 2026No match—
Pennsylvania Medicheck · Nov 4, 2026No match—
Washington HCA · Nov 4, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Order and Referring Only - Internal Medicine (IA)

Part D prescriptions in 2024

Prescriptions (claims)83 · 85 30-day fills
Patients38
Total drug cost$10,527
Generic share75% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$204.00 · 5 payments from 5 companies
  • 2024$393.62 · 6 payments from 4 companies

Top paying companies in 2025

What the 2025 payments were for

  • Food and Beverage$204.00 · 5 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Milwaukee

All Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Wisconsin →